(TEP) Teleperformance SE - Overview
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000051807
Stock: Customer Service, Back Office, Digital CX, AI Solutions, BPO
Total Rating 38
Risk 87
Buy Signal -1.67
Dividends
| Dividend Yield | 4.65% |
| Yield on Cost 5y | 1.68% |
| Yield CAGR 5y | 15.02% |
| Payout Consistency | 96.6% |
| Payout Ratio | 52.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 42.6% |
| Relative Tail Risk | -4.26% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.16 |
| Alpha | -48.03 |
| Character TTM | |
|---|---|
| Beta | 0.061 |
| Beta Downside | 0.198 |
| Drawdowns 3y | |
|---|---|
| Max DD | 76.98% |
| CAGR/Max DD | -0.50 |
Description: TEP Teleperformance SE January 09, 2026
Teleperformance SE (Ticker: TEP) is a Paris-based digital business services firm that operates globally through Core Services and Specialized Services segments. It delivers a broad portfolio that includes customer relationship and technical support, back-office processing, digital CX platforms, AI-driven speech understanding, and a range of outsourcing solutions such as recruitment, visa processing, and healthcare support. Its client base spans automotive, energy, media, government, technology, travel, hospitality, finance, insurance, retail, telecom, and video-games industries.
Recent data shows Teleperformance generated €8.2 billion in revenue for FY 2023, a 5 % year-over-year increase, with an operating margin of roughly 6 % as it scales AI-enabled services. The company’s growth is closely tied to macro-level drivers such as rising labor-cost pressures in developed markets, accelerating digital transformation spending, and the expanding demand for omnichannel customer experience solutions across B2B and B2C sectors.
For a deeper, data-rich assessment of Teleperformance’s valuation dynamics, you might find ValueRay’s analytical tools worth exploring.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 1.10b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.22 > 0.02 and ΔFCF/TA 8.20 > 1.0 |
| NWC/Revenue: 1.75% < 20% (prev 5.34%; Δ -3.59% < -1%) |
| CFO/TA 0.24 > 3% & CFO 2.95b > Net Income 1.10b |
| Net Debt (4.49b) to EBITDA (3.36b): 1.33 < 3 |
| Current Ratio: 1.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (59.4m) vs 12m ago 0.57% < -2% |
| Gross Margin: 22.21% > 18% (prev 0.19%; Δ 2202 % > 0.5%) |
| Asset Turnover: 189.6% > 50% (prev 139.6%; Δ 49.98% > 0%) |
| Interest Coverage Ratio: 4.18 > 6 (EBITDA TTM 3.36b / Interest Expense TTM 523.0m) |
Altman Z'' 3.02
| A: 0.03 (Total Current Assets 3.97b - Total Current Liabilities 3.62b) / Total Assets 12.10b |
| B: 0.31 (Retained Earnings 3.71b / Total Assets 12.10b) |
| C: 0.21 (EBIT TTM 2.19b / Avg Total Assets 10.43b) |
| D: 0.40 (Book Value of Equity 3.27b / Total Liabilities 8.14b) |
| Altman-Z'' Score: 3.02 = A |
Beneish M -2.91
| DSRI: 0.88 (Receivables 2.45b/1.72b, Revenue 19.78b/12.24b) |
| GMI: 0.87 (GM 22.21% / 19.38%) |
| AQI: 1.07 (AQ_t 0.56 / AQ_t-1 0.53) |
| SGI: 1.62 (Revenue 19.78b / 12.24b) |
| TATA: -0.15 (NI 1.10b - CFO 2.95b) / TA 12.10b) |
| Beneish M-Score: -2.91 (Cap -4..+1) = A |
What is the price of TEP shares?
As of February 07, 2026, the stock is trading at EUR 52.18 with a total of 237,201 shares traded.
Over the past week, the price has changed by -4.43%, over one month by -17.17%, over three months by -13.49% and over the past year by -41.07%.
Over the past week, the price has changed by -4.43%, over one month by -17.17%, over three months by -13.49% and over the past year by -41.07%.
Is TEP a buy, sell or hold?
Teleperformance SE has no consensus analysts rating.
What are the forecasts/targets for the TEP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 97.7 | 87.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 38.5 | -26.2% |
TEP Fundamental Data Overview February 03, 2026
Market Cap USD = 3.75b (3.17b EUR * 1.1801 EUR.USD)
P/E Trailing = 6.7658
P/E Forward = 3.7879
P/S = 0.3076
P/B = 0.7826
Revenue TTM = 19.78b EUR
EBIT TTM = 2.19b EUR
EBITDA TTM = 3.36b EUR
Long Term Debt = 3.33b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.79b EUR (from shortTermDebt, last quarter)
Debt = 5.71b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.49b EUR (from netDebt column, last quarter)
Enterprise Value = 7.66b EUR (3.17b + Debt 5.71b - CCE 1.23b)
Interest Coverage Ratio = 4.18 (Ebit TTM 2.19b / Interest Expense TTM 523.0m)
EV/FCF = 2.92x (Enterprise Value 7.66b / FCF TTM 2.62b)
FCF Yield = 34.26% (FCF TTM 2.62b / Enterprise Value 7.66b)
FCF Margin = 13.27% (FCF TTM 2.62b / Revenue TTM 19.78b)
Net Margin = 5.58% (Net Income TTM 1.10b / Revenue TTM 19.78b)
Gross Margin = 22.21% ((Revenue TTM 19.78b - Cost of Revenue TTM 15.39b) / Revenue TTM)
Gross Margin QoQ = 10.67% (prev 31.46%)
Tobins Q-Ratio = 0.63 (Enterprise Value 7.66b / Total Assets 12.10b)
Interest Expense / Debt = 2.52% (Interest Expense 144.0m / Debt 5.71b)
Taxrate = 33.06% (123.0m / 372.0m)
NOPAT = 1.46b (EBIT 2.19b * (1 - 33.06%))
Current Ratio = 1.10 (Total Current Assets 3.97b / Total Current Liabilities 3.62b)
Debt / Equity = 1.45 (Debt 5.71b / totalStockholderEquity, last quarter 3.95b)
Debt / EBITDA = 1.33 (Net Debt 4.49b / EBITDA 3.36b)
Debt / FCF = 1.71 (Net Debt 4.49b / FCF TTM 2.62b)
Total Stockholder Equity = 4.25b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.57% (Net Income 1.10b / Total Assets 12.10b)
RoE = 25.97% (Net Income TTM 1.10b / Total Stockholder Equity 4.25b)
RoCE = 28.86% (EBIT 2.19b / Capital Employed (Equity 4.25b + L.T.Debt 3.33b))
RoIC = 16.71% (NOPAT 1.46b / Invested Capital 8.76b)
WACC = 3.28% (E(3.17b)/V(8.89b) * Re(6.14%) + D(5.71b)/V(8.89b) * Rd(2.52%) * (1-Tc(0.33)))
Discount Rate = 6.14% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.18%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈2.05b ; Y1≈2.53b ; Y5≈4.30b
Fair Price DCF = 2078 (EV 125.33b - Net Debt 4.49b = Equity 120.84b / Shares 58.1m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -14.29 | EPS CAGR: -58.49% | SUE: 0.0 | # QB: 0
Revenue Correlation: 49.40 | Revenue CAGR: 18.53% | SUE: 1.54 | # QB: 1
EPS next Year (2026-12-31): EPS=14.05 | Chg30d=-0.290 | Revisions Net=-3 | Growth EPS=+7.1% | Growth Revenue=+0.3%
P/E Trailing = 6.7658
P/E Forward = 3.7879
P/S = 0.3076
P/B = 0.7826
Revenue TTM = 19.78b EUR
EBIT TTM = 2.19b EUR
EBITDA TTM = 3.36b EUR
Long Term Debt = 3.33b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.79b EUR (from shortTermDebt, last quarter)
Debt = 5.71b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.49b EUR (from netDebt column, last quarter)
Enterprise Value = 7.66b EUR (3.17b + Debt 5.71b - CCE 1.23b)
Interest Coverage Ratio = 4.18 (Ebit TTM 2.19b / Interest Expense TTM 523.0m)
EV/FCF = 2.92x (Enterprise Value 7.66b / FCF TTM 2.62b)
FCF Yield = 34.26% (FCF TTM 2.62b / Enterprise Value 7.66b)
FCF Margin = 13.27% (FCF TTM 2.62b / Revenue TTM 19.78b)
Net Margin = 5.58% (Net Income TTM 1.10b / Revenue TTM 19.78b)
Gross Margin = 22.21% ((Revenue TTM 19.78b - Cost of Revenue TTM 15.39b) / Revenue TTM)
Gross Margin QoQ = 10.67% (prev 31.46%)
Tobins Q-Ratio = 0.63 (Enterprise Value 7.66b / Total Assets 12.10b)
Interest Expense / Debt = 2.52% (Interest Expense 144.0m / Debt 5.71b)
Taxrate = 33.06% (123.0m / 372.0m)
NOPAT = 1.46b (EBIT 2.19b * (1 - 33.06%))
Current Ratio = 1.10 (Total Current Assets 3.97b / Total Current Liabilities 3.62b)
Debt / Equity = 1.45 (Debt 5.71b / totalStockholderEquity, last quarter 3.95b)
Debt / EBITDA = 1.33 (Net Debt 4.49b / EBITDA 3.36b)
Debt / FCF = 1.71 (Net Debt 4.49b / FCF TTM 2.62b)
Total Stockholder Equity = 4.25b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.57% (Net Income 1.10b / Total Assets 12.10b)
RoE = 25.97% (Net Income TTM 1.10b / Total Stockholder Equity 4.25b)
RoCE = 28.86% (EBIT 2.19b / Capital Employed (Equity 4.25b + L.T.Debt 3.33b))
RoIC = 16.71% (NOPAT 1.46b / Invested Capital 8.76b)
WACC = 3.28% (E(3.17b)/V(8.89b) * Re(6.14%) + D(5.71b)/V(8.89b) * Rd(2.52%) * (1-Tc(0.33)))
Discount Rate = 6.14% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.18%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈2.05b ; Y1≈2.53b ; Y5≈4.30b
Fair Price DCF = 2078 (EV 125.33b - Net Debt 4.49b = Equity 120.84b / Shares 58.1m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -14.29 | EPS CAGR: -58.49% | SUE: 0.0 | # QB: 0
Revenue Correlation: 49.40 | Revenue CAGR: 18.53% | SUE: 1.54 | # QB: 1
EPS next Year (2026-12-31): EPS=14.05 | Chg30d=-0.290 | Revisions Net=-3 | Growth EPS=+7.1% | Growth Revenue=+0.3%